Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Neil Patel

Podiatrist, Foot & Ankle Surgery La Verne, CA Doctor of Podiatric Medicine

NPI 1093262099 CMS profile 2142395

1075 Bonita Ave, La Verne, CA 91750

Open in the dashboard

General payments

$20,786

253 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Neil Patel of La Verne, CA is reported in the CMS Open Payments database as having received $20,786 across 253 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,149 17
2024 General $2,228 26
2023 General $1,789 25
2022 General $1,855 16
2021 General $3,962 67
2020 General $5,052 77
2019 General $4,752 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Neil Patel
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Neil Patel were reported at $1,149. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Neil Patel Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $4,752 $389 $118–$1,406 $163
2020 $5,052 $191 $62–$691 $114
2021 $3,962 $329 $104–$1,341 $132
2022 $1,855 $419 $125–$1,611 $149
2023 $1,789 $377 $128–$1,164 $160
2024 $2,228 $394 $134–$1,168 $164
2025 $1,149 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $3,298 42 payments
  2. Stryker Corporation $3,187 49 payments
  3. Arthrex, Inc. $3,013 12 payments
  4. TissueTech, Inc. $2,332 23 payments
  5. Integra LifeSciences Corporation $2,296 25 payments
  6. Mid-Atlantic Surgical Systems, LLC $1,174 2 payments
  7. Smith+Nephew, Inc. $1,160 41 payments
  8. Treace Medical Concepts, Inc. $1,008 11 payments
  9. Acera Surgical, Inc. $608 5 payments
  10. Musculoskeletal Transplant Foundation Inc. $480 4 payments
  11. Other $2,230 39 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $12,585 232 payments
  2. Education $4,026 4 payments
  3. Travel and Lodging $3,425 16 payments
  4. Consulting Fee $750 1 payment
Products named General payments · program years 2019–2025
  1. Stratum Foot Plating System $1,940 15 payments
  2. PRIMATRIX $1,401 12 payments
  3. INTEGRA DERMAL REGENERATION TEMPLATE $1,401 12 payments
  4. Integra Recon-Skin And Wound $1,254 8 payments
  5. Integra Recon-Skin And Wound $1,254 8 payments
  6. Integra Recon-Skin And Wound $1,254 8 payments
  7. NEOX $1,076 14 payments
  8. CLARIX $1,076 14 payments
  9. PANTA NAIL $651 9 payments
  10. HALLU-LOCK $651 9 payments
  11. Other $14,728 270 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

21

Median for Podiatry: 160

Drug cost

$425

Median for Podiatry: $2,368

Branded share of claims

0%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Doxycycline Monohydrate Generic 21 $425

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 59 billing codes

Paid by Medicare

$2,790,909

Medicare's payments for the services billed

Medicare patients

708

Average age 79

Services billed

3,211

420 women, 288 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Depression 58%
Arthritis 55%
Alzheimer's or dementia 54%
Diabetes 53%
Chronic kidney disease 43%
Heart failure 41%
Ischemic heart disease 38%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

253 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record